KR102242238B1 - Substituted or unsubstituted 4-bromo-2-fluoroquinoline, method of the same and 2,4 substituted quinoline compounds containing them - Google Patents

Substituted or unsubstituted 4-bromo-2-fluoroquinoline, method of the same and 2,4 substituted quinoline compounds containing them Download PDF

Info

Publication number
KR102242238B1
KR102242238B1 KR1020190038505A KR20190038505A KR102242238B1 KR 102242238 B1 KR102242238 B1 KR 102242238B1 KR 1020190038505 A KR1020190038505 A KR 1020190038505A KR 20190038505 A KR20190038505 A KR 20190038505A KR 102242238 B1 KR102242238 B1 KR 102242238B1
Authority
KR
South Korea
Prior art keywords
bromo
substituted
fluoroquinoline
unsubstituted
formula
Prior art date
Application number
KR1020190038505A
Other languages
Korean (ko)
Other versions
KR20200067073A (en
Inventor
조은진
김동인
박도담
채터지 탄매이
Original Assignee
중앙대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 중앙대학교 산학협력단 filed Critical 중앙대학교 산학협력단
Publication of KR20200067073A publication Critical patent/KR20200067073A/en
Application granted granted Critical
Publication of KR102242238B1 publication Critical patent/KR102242238B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

본 발명은 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물, 이의 제조 방법 및 이를 포함하는 2,4 치환된 퀴놀린 화합물에 관한 것으로, 트리브로모플루오로메탄(Tribromofluoromethane, CBr3F)과 치환된 또는 비치환된 2-알키닐 아닐린(2-alkynyl anilines) 화합물을 아민 염기성 용액 내에서 반응시켜 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물을 제조하고, 상기 제조된 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물을 빌딩블록(buliding block)으로 이용하여 2,4 치환된 퀴놀린 화합물을 제공한다.The present invention relates to a substituted or unsubstituted 4-bromo-2-fluoroquinoline compound, a method for preparing the same, and a 2,4 substituted quinoline compound including the same, tribromofluoromethane (CBr 3 F) reacting with a substituted or unsubstituted 2-alkynyl anilines compound in an amine basic solution to prepare a substituted or unsubstituted 4-bromo-2-fluoroquinoline compound, A 2,4 substituted quinoline compound is provided by using the prepared substituted or unsubstituted 4-bromo-2-fluoroquinoline compound as a building block.

Description

치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물, 이의 제조 방법 및 이를 포함하는 2,4 치환된 퀴놀린 화합물{SUBSTITUTED OR UNSUBSTITUTED 4-BROMO-2-FLUOROQUINOLINE, METHOD OF THE SAME AND 2,4 SUBSTITUTED QUINOLINE COMPOUNDS CONTAINING THEM}Substituted or unsubstituted 4-bromo-2-fluoroquinoline compound, a method for preparing the same, and a 2,4 substituted quinoline compound comprising the same ,4 SUBSTITUTED QUINOLINE COMPOUNDS CONTAINING THEM}

본 발명은 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물, 이의 제조 방법 및 이를 포함하는 2,4 치환된 퀴놀린 화합물에 관한 것으로, 보다 구체적으로는 트리브로모플루오로메탄과 치환된 또는 비치환된 2-알키닐 아닐린 화합물을 반응시켜 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린을 제조하고, 빌딩 블록(buidling block)으로서 이를 사용하여 제조된 2,4 치환된 퀴놀린 화합물에 관한 것이다.The present invention relates to a substituted or unsubstituted 4-bromo-2-fluoroquinoline compound, a method for preparing the same, and a 2,4 substituted quinoline compound comprising the same, and more specifically, to tribromofluoromethane and 2,4 prepared by reacting a substituted or unsubstituted 2-alkynyl aniline compound to prepare a substituted or unsubstituted 4-bromo-2-fluoroquinoline, and using it as a building block It relates to a substituted quinoline compound.

할로젠(Halogen)은 주기율표의 17족에 속하는 원소들로, 요오드(Iodine, I), 브로민(Bromine, Br), 염소(Chlorine, Cl), 플루오린(Fluorine, F) 등이 있다. 할로젠 원소는 비금속성 및 반응성이 크기 때문에 주로 다른 원소와 화합물의 상태로 존재한다. 구체적으로는, 할로젠은 화합물의 합성 반응 내에서 할로젠 각각의 원소마다 반응성 및 선택성과 같은 특성이 매우 다르기 때문에 여러 개의 할로젠을 가지는 화합물은 여러 반응을 선택적으로 가능하게 한다. 이러한 이유로 유기 화합물을 합성하는 유기 반응에서 할로젠은 전구 물질로 가장 널리 사용된다.Halogen is an element belonging to group 17 of the periodic table, and includes iodine (I), bromine (Br), chlorine (Cl), and fluorine (F). Because halogen elements are non-metallic and highly reactive, they mainly exist in the form of other elements and compounds. Specifically, since halogen has very different properties such as reactivity and selectivity for each element of halogen in the synthesis reaction of the compound, a compound having several halogens enables several reactions selectively. For this reason, halogen is most widely used as a precursor in organic reactions for synthesizing organic compounds.

한편, 천연물, 의약품 등에 사용되는 화합물은 여러 단계의 과정이 거쳐 합성된다. 예를 들어. 의약품의 중요한 원료인 퀴놀린을 구성 성분으로 가지는 약품을 합성할 때, 퀴놀린 자체를 합성하는 과정을 비롯하여 다른 여러 반응 공정을 이용하여 합성된다. 이러한 반응 과정을 거쳐 합성된 화합물은 그 과정이 매우 어렵고 복잡하여 반응 조건을 단순하고 실용성을 실현하기 위한 많은 연구가 진행 중이다.Meanwhile, compounds used in natural products and pharmaceuticals are synthesized through several steps. For example. When synthesizing a drug containing quinoline, an important raw material for pharmaceuticals, as a constituent component, it is synthesized using several other reaction processes, including the process of synthesizing quinoline itself. Compounds synthesized through such a reaction process are very difficult and complex, and many studies are underway to realize simple and practical reaction conditions.

이와 같이, 고도로 기능화된 복합 약품 등을 제조하기 위한 가장 효율적인 방법으로는 빌딩 블록(buidling block)을 사용하는 것이다. 빌딩 블록에서 여러 개의 할로젠의 이용은 여러 반응을 선택적으로 가능하게 할 수 있으므로, 유용한 빌딩 블록으로 사용할 수 있다. 하지만, 현재 여러 개의 할로젠을 도입하는 것과 동시에 헤테로 고리를 합성하는 것과 같은 다중성 빌딩 블록의 합성 방법에 대해서는 보고되지 않았다. 이와 같이 다중성 빌딩 블록의 합성은 여전히 어려운 과제로 남아 있어, 실용적으로 사용하기 위해서는 많은 연구 및 개발이 필요한 상황이다.In this way, the most efficient method for manufacturing a highly functionalized complex drug is to use a building block (buidling block). The use of multiple halogens in a building block can be used as a useful building block because it can selectively enable multiple reactions. However, at present, a method for synthesizing a multiplicity building block such as synthesizing a heterocycle simultaneously with introducing several halogens has not been reported. As such, the synthesis of multiplicity building blocks still remains a difficult task, and a lot of research and development is required for practical use.

본 발명의 일 목적은 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린의 제조 방법을 제공하는 것이다.One object of the present invention is to provide a method for preparing a substituted or unsubstituted 4-bromo-2-fluoroquinoline.

본 발명의 다른 목적은 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물을 제공하는 것이다.Another object of the present invention is to provide a substituted or unsubstituted 4-bromo-2-fluoroquinoline compound.

본 발명의 또 다른 목적은 다중성 빌딩 블록으로써 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린을 이용하여 제조된, 2,4 치환된 퀴놀린 화합물을 제공하는 것이다.Another object of the present invention is to provide a 2,4 substituted quinoline compound prepared using substituted or unsubstituted 4-bromo-2-fluoroquinoline as a multiplicity building block.

본 발명의 일 목적을 위한 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린의 제조 방법은 트리브로모플루오로메탄과 치환된 또는 비치환된 2-알키닐 아닐린 화합물을 반응시킴을 포함한다.A method for preparing a substituted or unsubstituted 4-bromo-2-fluoroquinoline for an object of the present invention is to react a substituted or unsubstituted 2-alkynyl aniline compound with tribromofluoromethane. Includes.

일 실시예에서, 상기 반응은 아민 염기성 용액 내에 이뤄질 수 있다.In one embodiment, the reaction may be carried out in an amine basic solution.

일 실시예에서, 상기 반응은 광을 조사하면서 이뤄질 수 있다.In one embodiment, the reaction may be accomplished while irradiating light.

일 실시예에서, 상기 아민 염기성 용액은 NMM, DABCO, DBU, TEA, TMEDA, 및 N-벤질메틸아민(N-benzylmethylamine) 중 어느 하나 이상의 용액일 수 있다.In one embodiment, the amine basic solution may be any one or more of NMM, DABCO, DBU, TEA, TMEDA, and N-benzylmethylamine.

일 실시예에서, 상기 용액의 용매는 DMF, DMSO, THF, 1,4-디옥산(1,4-dioxane), NMP, MeCN, 벤젠(benzene), H2O 및 DCE 중 어느 하나 이상일 수 있다.In one embodiment, the solvent of the solution may be any one or more of DMF, DMSO, THF, 1,4-dioxane, NMP, MeCN, benzene, H2O, and DCE.

일 실시예에서, 상기 용액의 용매는 염소계 용매일 수 있다.In one embodiment, the solvent of the solution may be a chlorine-based solvent.

일 실시예에서, 상기 반응은 무산소 분위기에서 수행할 수 있다.In one embodiment, the reaction may be carried out in an oxygen-free atmosphere.

일 실시예에서, 치환 또는 비치환된 2-알키닐 아닐린 화합물은 아래 화학식 1일 수 있다.In one embodiment, the substituted or unsubstituted 2-alkynyl aniline compound may be of Formula 1 below.

<화학식 1><Formula 1>

Figure 112019033830618-pat00001
Figure 112019033830618-pat00001

상기 식에서, R1 및 R2은 각각 독립적으로 수소, 할로겐, 시아노, 치환된 또는 비치환된 알킬기(alkyl), 치환된 또는 비치환된 아릴기(Aryl), 치환된 또는 비치환된 알케닐 또는 치환된 또는 비치환된 알콕시이다.In the above formula, R 1 and R 2 are each independently hydrogen, halogen, cyano, substituted or unsubstituted alkyl group, substituted or unsubstituted aryl group (Aryl), substituted or unsubstituted alkenyl Or substituted or unsubstituted alkoxy.

본 발명의 다른 목적을 위한 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물은 아래 화학식 2이다.A substituted or unsubstituted 4-bromo-2-fluoroquinoline compound for another purpose of the present invention is the following formula (2).

<화학식 2><Formula 2>

Figure 112019033830618-pat00002
Figure 112019033830618-pat00002

상기 식에서, R1 및 R2은 각각 독립적으로 수소, 할로겐, 시아노, 치환된 또는 비치환된 알킬기(alkyl), 치환된 또는 비치환된 아릴기(Aryl), 치환된 또는 비치환된 알케닐 또는 치환된 또는 비치환된 알콕시이다.In the above formula, R 1 and R 2 are each independently hydrogen, halogen, cyano, substituted or unsubstituted alkyl group, substituted or unsubstituted aryl group (Aryl), substituted or unsubstituted alkenyl Or substituted or unsubstituted alkoxy.

일 실시예에서, 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물은 아래 화학식일 수 있다.In one embodiment, the substituted or unsubstituted 4-bromo-2-fluoroquinoline compound may be of the formula below.

Figure 112019033830618-pat00003
Figure 112019033830618-pat00003

Figure 112019033830618-pat00004
Figure 112019033830618-pat00004

Figure 112019033830618-pat00005
Figure 112019033830618-pat00005

Figure 112019033830618-pat00006
Figure 112019033830618-pat00006

Figure 112019033830618-pat00007
Figure 112019033830618-pat00007

Figure 112019033830618-pat00008
Figure 112019033830618-pat00008

Figure 112019033830618-pat00009
Figure 112019033830618-pat00009

Figure 112019033830618-pat00010
Figure 112019033830618-pat00010

Figure 112019033830618-pat00011
Figure 112019033830618-pat00011

Figure 112019033830618-pat00012
Figure 112019033830618-pat00012

Figure 112019033830618-pat00013
Figure 112019033830618-pat00013

Figure 112019033830618-pat00014
Figure 112019033830618-pat00014

Figure 112019033830618-pat00015
Figure 112019033830618-pat00015

Figure 112019033830618-pat00016
Figure 112019033830618-pat00016

Figure 112019033830618-pat00017
Figure 112019033830618-pat00017

Figure 112019033830618-pat00018
Figure 112019033830618-pat00018

Figure 112019033830618-pat00019
Figure 112019033830618-pat00019

Figure 112019033830618-pat00020
Figure 112019033830618-pat00020

Figure 112019033830618-pat00021
Figure 112019033830618-pat00021

Figure 112019033830618-pat00022
Figure 112019033830618-pat00022

Figure 112019033830618-pat00023
Figure 112019033830618-pat00023

Figure 112019033830618-pat00024
Figure 112019033830618-pat00024

본 발명의 또 다른 목적을 위한 2,4 치환된 퀴놀린 화합물은 빌딩 블록(buidling block)으로서 제9항의 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린을 이용한다.The 2,4 substituted quinoline compound for another object of the present invention uses the substituted or unsubstituted 4-bromo-2-fluoroquinoline of claim 9 as a building block.

본 발명의 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린의 제조 방법에 따르면, 트리브로모플루오로메탄과 치환된 또는 비치환된 2-알키닐 아닐린 화합물을 아민염기성 용액, 용매 및 광이 조사된 조건 하에서 반응시켜 여러 개의 할로젠을 가지는 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린을 제조할 수 있다. 또한 형성된 상기 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린을 빌딩 블록으로써 사용하여 2,4 치환된 퀴놀린 화합물를 제조할 수 있다According to the method for preparing a substituted or unsubstituted 4-bromo-2-fluoroquinoline of the present invention, tribromofluoromethane and a substituted or unsubstituted 2-alkynyl aniline compound are mixed with an amine basic solution and a solvent. And a substituted or unsubstituted 4-bromo-2-fluoroquinoline having several halogens by reacting under conditions irradiated with light. In addition, the formed substituted or unsubstituted 4-bromo-2-fluoroquinoline can be used as a building block to prepare a 2,4 substituted quinoline compound.

본 출원에서 사용한 용어는 단지 특정한 실시 예를 설명하기 위해 사용된 것으로서 본 발명을 한정하려는 의도가 아니다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 본 출원에서, "포함하다" 또는 "가지다" 등의 용어는 명세서 상에 기재된 특징, 단계, 동작, 구성요소, 부분품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 단계, 동작, 구성요소, 부분품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다.The terms used in the present application are only used to describe specific embodiments and are not intended to limit the present invention. Singular expressions include plural expressions unless the context clearly indicates otherwise. In the present application, terms such as "comprise" or "have" are intended to designate the presence of features, steps, actions, components, parts, or combinations thereof described in the specification, but one or more other features or steps. It is to be understood that it does not preclude the possibility of addition or presence of, operations, components, parts, or combinations thereof.

다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미를 가지고 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥 상 가지는 의미와 일치하는 의미를 가지는 것으로 해석되어야 하며, 본 출원에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.Unless otherwise defined, all terms used herein including technical or scientific terms have the same meaning as commonly understood by one of ordinary skill in the art to which the present invention belongs. Terms as defined in a commonly used dictionary should be interpreted as having a meaning consistent with the meaning in the context of the related technology, and should not be interpreted as an ideal or excessively formal meaning unless explicitly defined in the present application. Does not.

본 발명은 트리브로모플루오로메탄(Tribromofluoromethane, CBr3F)과 치환된 또는 비치환된 2-알키닐 아닐린(2-alkynyl anilines) 화합물을 이용하여, 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물 제조한다.The present invention uses a tribromofluoromethane (CBr 3 F) and a substituted or unsubstituted 2-alkynyl anilines compound, a substituted or unsubstituted 4-bromo- Prepare a 2-fluoroquinoline compound.

상기 트리브로모플루오로메탄(CBr3F)은 Br 및 F의 공급원으로써, 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물 제조에 사용할 수 있다.The tribromofluoromethane (CBr 3 F) is a source of Br and F, and can be used to prepare a substituted or unsubstituted 4-bromo-2-fluoroquinoline compound.

상기 치환된 또는 비치환된 2-알키닐 아닐린(2-alkynyl anilines) 화합물은 하기의 화학식 1로 나타낸다.The substituted or unsubstituted 2-alkynyl anilines compound is represented by the following formula (1).

<화학식 1><Formula 1>

Figure 112019033830618-pat00025
Figure 112019033830618-pat00025

상기 반응식 1에서, R1 및 R2는 각각 독립적으로 수소, 할로겐, 시아노, 치환된 또는 비치환된 알킬기(alkyl), 치환된 또는 비치환된 아릴기(Aryl), 치환된 또는 비치환된 알케닐 또는 치환된 또는 비치환된 알콕시이다.In Scheme 1, R 1 and R 2 are each independently hydrogen, halogen, cyano, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group (Aryl), a substituted or unsubstituted Alkenyl or substituted or unsubstituted alkoxy.

본 발명의 치환 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물은 하기의 화학식 2로 나타낸다. The substituted or unsubstituted 4-bromo-2-fluoroquinoline compound of the present invention is represented by the following formula (2).

<화학식 2><Formula 2>

Figure 112019033830618-pat00026
Figure 112019033830618-pat00026

본 발명의 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물은 트리브로모플루오로메탄(Tribromofluoromethane, CBr3F)과 치환된 또는 비치환된 2-알키닐 아닐린(2-alkynyl anilines) 화합물을 이용하여 하기의 반응식 1로 나타내는 반응을 통하여 제조한다. The substituted or unsubstituted 4-bromo-2-fluoroquinoline compound of the present invention is tribromofluoromethane (CBr 3 F) and a substituted or unsubstituted 2-alkynyl aniline (2-alkynyl). anilines) is prepared through a reaction represented by Scheme 1 below using a compound.

<반응식 1>

Figure 112020111055009-pat00077
<Reaction Scheme 1>
Figure 112020111055009-pat00077

삭제delete

상기 반응식 1에서, R1 및 R2은 각각 독립적으로 수소, 할로겐, 시아노, 치환된 또는 비치환된 알킬기(alkyl), 치환된 또는 비치환된 아릴기(Aryl), 치환된 또는 비치환된 알케닐 또는 치환된 또는 비치환된 알콕시이다.In Scheme 1, R 1 and R 2 are each independently hydrogen, halogen, cyano, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group (Aryl), a substituted or unsubstituted Alkenyl or substituted or unsubstituted alkoxy.

일 실시예에서, 상기 치환 또는 비치환된 2-알키닐 아닐린 화합물 대신 화학식 3으로 나타내는 2-에티닐 아닐린(ethynyl aniline) 화합물을 사용할 수 있다.In one embodiment, instead of the substituted or unsubstituted 2-alkynyl aniline compound, a 2-ethynyl aniline compound represented by Formula 3 may be used.

<화학식 3><Formula 3>

Figure 112019033830618-pat00028
Figure 112019033830618-pat00028

상기 반응식 1로 나타내는 상기 반응은 아민 염기성 용액 내에서 이루어 질 수 있으며, 상기 아민 염기성 용액은 N-메틸모르폴린(N-methylmorpholine, NMM), 1,4-디아자비시클로[2,2,2]옥탄( 1,4-diazabicyclo[2.2.2]octane, DABCO) 1,8-디아자바이사이클로운데크-7-엔(1,8-diazabicycloundec-7-ene, DBU), 테트라메틸에틸렌디아민(Tetramethylethylenediamine, TMEDA), 트릴에틸아민(Triethylamine, TEA) 및 N-벤질메틸아민(N-benzylmethylamine) 중 어느 하나 이상의 용액임일 수 있고, 바람직하게는, 아민 염기성 용액으로 N-메틸모르폴린(NMM)를 이용할 수 있다.The reaction represented by Scheme 1 may be performed in an amine basic solution, and the amine basic solution is N-methylmorpholine (NMM), 1,4-diazabicyclo[2,2,2] Octane (1,4-diazabicyclo[2.2.2]octane, DABCO) 1,8-diazabicycloundec-7-ene (1,8-diazabicycloundec-7-ene, DBU), tetramethylethylenediamine (Tetramethylethylenediamine, TMEDA), triethylamine (TEA) and N-benzylmethylamine (N-benzylmethylamine) may be any one or more solutions, preferably, N-methylmorpholine (NMM) can be used as an amine basic solution. have.

상기 아민 염기성 용액의 용매는 디메틸포름아미드(dimethylformamide, DMF), 디메틸설폭사이드(Dimethyl sulfoxide, DMSO), 1,4-디옥산(1,4-dioxane), 메틸피롤리돈(N-Methyl-2-pyrrolidone, NMP), 아세토니트릴(Acetonitrile, MeCN), 벤젠(benzene), 테트라하이드로퓨란(Tetrahydrofuran, THF), 물(H2O) 및 디클로로에탄(dichloroethane, DCE) 중 어느 하나 이상의 용매일 수 있다. 상기 용액의 용매는 염소계 용매일 수 있다. 바람직하게는, 상기 용액의 용매는 디클로로에탄(DCE)일 수 있다.The solvent of the basic amine solution is dimethylformamide (DMF), dimethyl sulfoxide (DMSO), 1,4-dioxane (1,4-dioxane), methylpyrrolidone (N-Methyl-2). -Pyrrolidone, NMP), acetonitrile (MeCN), benzene (benzene), tetrahydrofuran (THF), water (H 2 O) and dichloroethane (dichloroethane, DCE) may be any one or more solvent . The solvent of the solution may be a chlorine-based solvent. Preferably, the solvent of the solution may be dichloroethane (DCE).

또한, 상기 반응은 광을 조사하면서 이루어질 수 있다. In addition, the reaction may be performed while irradiating light.

또한, 상기 반응은 무산소 분위기에서에서 수행될 수 있다.In addition, the reaction may be carried out in an oxygen-free atmosphere.

이하, 본 발명의 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 제조 방법을 다음의 반응 조건의 최적화 평가를 통해 상세히 설명한다.Hereinafter, a method for preparing a substituted or unsubstituted 4-bromo-2-fluoroquinoline of the present invention will be described in detail through an optimization evaluation of the following reaction conditions.

반응 조건의 최적화 평가Optimization evaluation of reaction conditions

반응 조건의 최적화 평가를 하기 위하여, 반응물로, 0.3 mmol의 트리브로모플루오로메탄(tribromofluoromethane, CBr3F)및 0.1 mmol의 2-에티닐 아닐린(2-ethynylaniline)을 이용하여 반응시켜 치환 또는 비치환된 4-브로모-2-플루오로퀴놀린(4-bromo-2-fluoroquinoline)을 수득하였다.In order to evaluate the optimization of the reaction conditions, as a reactant, 0.3 mmol of tribromofluoromethane (CBr 3 F) and 0.1 mmol of 2-ethynylaniline were used to react and substituted or provided. To obtain a ringed 4-bromo-2-fluoroquinoline (4-bromo-2-fluoroquinoline).

상기 반응은 다음과 같이 반응식 2로 나타낸다.The reaction is represented by Scheme 2 as follows.

<반응식 2><Reaction Scheme 2>

Figure 112019033830618-pat00029
Figure 112019033830618-pat00029

상기 반응을 형성하기 위하여, 상기 반응물들의 혼합물에 0.2 mol의 용매(solvent)및 염기(base)성 용액(3 당량)을 첨가하고, 백색 LED (18W, EvoluChem company)를 아르곤(argon) 분위기 하에서 15시간 동안 반응시켰고, 상기 반응으로 인하여 치환 또는 비치환된 4-브로모-2-플루오로퀴놀린(4-bromo-2-fluoroquinoline) 샘플 1 내지 20을 얻었다. 상기 샘플 1 내지 샘플 20의 제조에서 이용된 반응 조건들의 상세한 내용은 표 1에 나타냈다.To form the reaction, 0.2 mol of a solvent and a base solution (3 equivalents) were added to the mixture of reactants, and a white LED (18W, EvoluChem company) was added to 15 under an argon atmosphere. The reaction was performed for a period of time, and a substituted or unsubstituted 4-bromo-2-fluoroquinoline sample 1 to 20 was obtained due to the reaction. Details of the reaction conditions used in the preparation of Samples 1 to 20 are shown in Table 1.

상기 반응에 따른 샘플 1 내지 20의 수율을 가스 크로마토그래피(gas chromatography)를 이용하여 측정하였고, 그 결과를 표 1에 나타냈다.The yields of Samples 1 to 20 according to the reaction were measured using gas chromatography, and the results are shown in Table 1.

Figure 112019033830618-pat00030
Figure 112019033830618-pat00030

상기 표 1를 참조하면, 샘플 1 내지 샘플 3을 비교하여, 염기성 용액을 첨가를 제외하고 제조된 샘플 2 및 광을 조사하지 않는 분위기 하에서 제조된 샘플 3은 0%의 수율을 나타내 치환 또는 비치환된 4-브로모-2-플루오로퀴놀린을 제조하기 위한 반응이 이루어지지 않은 것을 확인할 수 있는 반면, 염기성 용액 및 백색 LED (18W)의 조건 하에서 제조된 샘플 1의 경우에는 수율 62%인 것을 확인할 수 있어 본 발명의 치환 또는 비치환된 4-브로모-2-플루오로퀴놀린이 합성된 것으로 볼 수 있다.Referring to Table 1, by comparing Samples 1 to 3, Sample 2 prepared except for the addition of a basic solution and Sample 3 prepared under an atmosphere not irradiated with light showed a yield of 0%, indicating a substituted or unsubstituted While it can be confirmed that the reaction for preparing the 4-bromo-2-fluoroquinoline was not made, it was confirmed that the yield was 62% in the case of Sample 1 prepared under the conditions of a basic solution and white LED (18W). It can be seen that the substituted or unsubstituted 4-bromo-2-fluoroquinoline of the present invention was synthesized.

샘플 4 내지 샘플 8을 통해서, 다양한 아민 염기성 용액의 존재하여 수행된 반응은 치환 또는 비치환된 4-브로모-2-플루오로퀴놀린을 제조할 수 있음을 확인할 수 있다. 이와 비교하여, 아스코르브산나트륨 및 탄산칼륨의 존재 하에서 수행된 샘플 8 및 샘플 9는 0%의 수율을 나타내는 것을 확인할 수 있으며, 이를 통해서, 본 발명에 따른 치환 또는 비치환된 4-브로모-2-플루오로퀴놀린을 제조하기 위한 반응에서 아민 염기가 반드시 필요하다는 것을 확인할 수 있다.Through Samples 4 to 8, it can be seen that the reaction performed in the presence of various amine basic solutions can produce substituted or unsubstituted 4-bromo-2-fluoroquinoline. In comparison, it can be seen that Samples 8 and 9 performed in the presence of sodium ascorbate and potassium carbonate show a yield of 0%, through which the substituted or unsubstituted 4-bromo-2 according to the present invention -It can be seen that an amine base is absolutely necessary in the reaction for preparing fluoroquinoline.

샘플 11 내지 샘플 18의 결과를 보면, 반응에서 사용할 수 있는 용매는 디메틸포름아미드(dimethylformamide, DMF), 디메틸설폭사이드(Dimethyl sulfoxide, DMSO), 1,4-디옥산(1,4-dioxane), 메틸피롤리돈(N-Methyl-2-pyrrolidone, NMP), 아세토니트릴(Acetonitrile, MeCN), 벤젠(benzene), 테트라하이드로퓨란(Tetrahydrofuran, THF), 물(H2O) 및 디클로로에탄(dichloroethane, DCE) 중 어느 하나 이상의 용매에서 이용할 수 있음을 확인할 수 있고, 특히, 용매로 디클로로에탄을 사용하여 제조된 샘플 18은 85%의 수율을 나타내어, 샘플들 중 가장 높은 수율을 나타내는 것을 확인할 수 있다. 이는, 샘플 18이 제조되는 반응에서, 용매로 사용된 디클로로에탄의 염소가 CBr2F 라디칼 생성 속도에 영향을 주어 반응 효율이 높아진 것으로 예상할 수 있다.Looking at the results of Samples 11 to 18, the solvents that can be used in the reaction are dimethylformamide (DMF), dimethyl sulfoxide (DMSO), 1,4-dioxane (1,4-dioxane), Methylpyrrolidone (NMP), acetonitrile (MeCN), benzene, tetrahydrofuran (THF), water (H 2 O) and dichloroethane (dichloroethane, DCE), it can be confirmed that it can be used in any one or more solvents, and in particular, Sample 18 prepared using dichloroethane as a solvent exhibited a yield of 85%, indicating the highest yield among the samples. This can be expected that in the reaction in which Sample 18 is prepared, chlorine in dichloroethane used as a solvent affects the rate of generation of CBr 2 F radicals, thereby increasing the reaction efficiency.

샘플 18과 비교하여 샘플 19의 결과를 확인해보면, 디클로로에탄을 사용하여 샘플 18과 같이 높은 수율을 예상할 수 있었으나, 85%의 수율을 나타내는 샘플 18과 달리 샘플 19는 공기 중에서 반응이 수행되어 29%의 수율을 나타내어, 샘플 19보다 적은 수율을 나타냈다. 이를 통해서, 산소의 존재는 반응에 영향을 주어 수율을 현저하게 감소시키는 것으로 볼 수 있다.When comparing the results of Sample 19 with Sample 18, dichloroethane was used to predict a high yield like Sample 18, but unlike Sample 18, which showed a yield of 85%, Sample 19 was reacted in air. % Yield, showing a lower yield than Sample 19. Through this, it can be seen that the presence of oxygen significantly reduces the yield by affecting the reaction.

샘플 20의 반응 조건을 확인해보면, 샘플 20은 365 nm의 수은 램프(Hg lamp)(600W) 조사 하에서 수행되어 제조되었다. 특히, 샘플 20은 수은 램프의 사용으로 반응 시간이 15시간에서 2시간으로 단축되어, 매우 빠른 반응 시간을 나타냄을 확인할 수 있다.Checking the reaction conditions of Sample 20, Sample 20 was prepared by performing under irradiation of 365 nm mercury lamp (600W). In particular, it can be seen that the reaction time of Sample 20 was shortened from 15 hours to 2 hours by the use of a mercury lamp, indicating a very fast reaction time.

실시예 1 : 4-브로모-2-플루오로퀴놀린 화합물의 제조Example 1: Preparation of 4-bromo-2-fluoroquinoline compound

자석 교반 막대가 구비(magnetic stir bar)된 개폐식 튜브(resealable tube)에 0.5 mmol의 2-에티닐 아닐린(2-ethynylaniline) 57.5μL, 1.5 mmol의 4-메틸모르폴린(NMM) 165μL 및 1.5 M의 디클로로에탄(dichloroethane, DCE)을 혼합하여 제1 혼합물을 제조한 후, 아르곤 가스를 상기 혼합물을 통해 10분동안 버블링(bubbling)시키고, 1.5 mmol의 트리브로모플루오로메탄(tribromofluoromethane, CBr3F) 23.9μL을 조심스럽게 첨가하여 제2 혼합물을 제조하였다. 이어서, 제2 혼합물이 담긴 상기 튜브를 실리콘 격벽 나사 캡으로 밀봉하고, 실온에서 백색 LED (18W, EvoluChem company)하에 16시간 동안 반응시켰다. 상기 반응 진행은 박층 크로마토그래피(Thin Layer Chromatography.TLC) 및 가스 크로마토그래피(gas chromatography)로 모니터링 하였다. 상기 반응 종료 후, 상기 제2 혼합물을 에틸아세테이트(Ethyl acetate, EA) 및 물로 희석시키고, 수성상(aqueous phase)은 에틸 아세테이트로 한층 더 추출되었다. 이어서, 결합된 유기층들은 무수 MgSO4상에서 건조시키고 진공 하에 농축시켰다. 잔류물은 헥산/EA(hexane/EA) (8/1)로 플래시 칼럼 크로마토그래피(flash column chromatography)로 정제하여 78%의 수율로 순수한 0.39 mmol의 4-브로모-2-플루오로퀴놀린 87.8 mg 을 제조하였다. 실시예 1에 따라 제조된 4-브로모-2-플루오로퀴놀린은 하기의 화학식 4로 나타낸다.0.5 mmol of 2-ethynylaniline 57.5 μL, 1.5 mmol of 4-methylmorpholine (NMM) 165 μL and 1.5 M in a resealable tube equipped with a magnetic stir bar. After preparing a first mixture by mixing dichloroethane (DCE), argon gas was bubbled through the mixture for 10 minutes, and 1.5 mmol of tribromofluoromethane (CBr 3 F) ) 23.9 μL was carefully added to prepare a second mixture. Then, the tube containing the second mixture was sealed with a silicone diaphragm screw cap, and reacted at room temperature under a white LED (18W, EvoluChem company) for 16 hours. The reaction progress was monitored by thin layer chromatography (TLC) and gas chromatography. After the reaction was completed, the second mixture was diluted with ethyl acetate (EA) and water, and the aqueous phase was further extracted with ethyl acetate. The combined organic layers were then dried over anhydrous MgSO 4 and concentrated in vacuo. The residue was purified by flash column chromatography with hexane/EA (8/1), and 87.8 mg of pure 0.39 mmol 4-bromo-2-fluoroquinoline in a yield of 78% Was prepared. 4-bromo-2-fluoroquinoline prepared according to Example 1 is represented by the following formula (4).

<화학식 4><Formula 4>

Figure 112019033830618-pat00031
Figure 112019033830618-pat00031

실시예 2 내지 실시예 21의 제조: 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물들의 제조Preparation of Examples 2 to 21: Preparation of substituted or unsubstituted 4-bromo-2-fluoroquinoline compounds

2-에티닐 아닐린(2-ethynylaniline) 대신, 2-에티닐-4-메틸아닐린(2-ethynyl-4-methylaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고, 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 2에 따른 4-브로모-2-플루오로-6-메틸퀴놀린(4-bromo-2-fluoro-6-methylquinoline)을 얻었다. 상기 4-브로모-2-플루오로-6-메틸퀴놀린(4-bromo-2-fluoro-6-methylquinoline)은 화학식 5로 나타낸다.Instead of 2-ethynylaniline, 2-ethynyl-4-methylaniline was used, and instead of white LED (18W, EvoluChem company), 365 nm (18W, EvoluChem compan), except for using 4-bromo-2-fluoro-6-methylquinoline (4-bromo-2-fluoro-6) according to Example 2 of the present invention through substantially the same process as in Example 1 -methylquinoline) was obtained. The 4-bromo-2-fluoro-6-methylquinoline is represented by Chemical Formula 5.

<화학식 5><Formula 5>

Figure 112019033830618-pat00032
Figure 112019033830618-pat00032

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 2-에티닐-5-메틸아닐린(2-ethynyl-5-methylaniline)을 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 3에 따른 4-브로모-2-플루오로-7-메틸퀴놀린(4-bromo-2-fluoro-7-methylquinoline)을 얻었다. 상기 4??브로모-2-플루오로-7-메틸퀴놀린(4-bromo-2-fluoro-7-methylquinoline)을 하기의 화학식 6으로 나타낸다.In addition, the present invention was carried out through substantially the same process as in Example 1, except that 2-ethynyl-5-methylaniline was used instead of 2-ethynylaniline. 4-bromo-2-fluoro-7-methylquinoline according to Example 3 was obtained. The 4?? bromo-2-fluoro-7-methylquinoline (4-bromo-2-fluoro-7-methylquinoline) is represented by the following formula (6).

<화학식 6><Formula 6>

Figure 112019033830618-pat00033
Figure 112019033830618-pat00033

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 4-부틸-2-에티닐아닐린 (4-butyl-2-ethynylaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 4에 따른 4-브로모-2-플루오로-7-메틸퀴놀린(4-bromo-2-fluoro-6-butylquinoline)을 얻었다. 상기 4-브로모-2-플루오로-7-메틸퀴놀린(4-bromo-2-fluoro-6-butylquinoline)을 하기의 화학식 7로 나타낸다.Also, instead of 2-ethynylaniline, 4-butyl-2-ethynylaniline Except for using (4-butyl-2-ethynylaniline) and using 365 nm (18W, EvoluChem compan) instead of a white LED (18W, EvoluChem company), implementation of the present invention through substantially the same process as in Example 1 According to Example 4, 4-bromo-2-fluoro-7-methylquinoline (4-bromo-2-fluoro-6-butylquinoline) was obtained. The 4-bromo-2-fluoro-7-methylquinoline is represented by the following formula (7).

<화학식 7><Formula 7>

Figure 112019033830618-pat00034
Figure 112019033830618-pat00034

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 2-에티닐-4,6-디메틸아닐린(2-ethynyl-4,6-dimethylaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 5에 따른 4-브로모-2-플루오로-6,8-디메틸퀴놀린(4-bromo-2-fluoro-6,8-dimethylquinoline)을 얻었다. 상기 4-브로모-2-플루오로-6,8-디메틸퀴놀린(4-bromo-2-fluoro-6,8-dimethylquinoline)은 하기의 화학식 8로 나타낸다.In addition, instead of 2-ethynylaniline, 2-ethynyl-4,6-dimethylaniline was used, and instead of white LED (18W, EvoluChem company), 4-bromo-2-fluoro-6,8-dimethylquinoline (4-bromo-2-fluoro-6,8-dimethylquinoline according to Example 5 of the present invention through substantially the same process as in Example 1 except that 365 nm (18W, EvoluChem compan) was used. bromo-2-fluoro-6,8-dimethylquinoline) was obtained. The 4-bromo-2-fluoro-6,8-dimethylquinoline is represented by Formula 8 below.

<화학식 8><Formula 8>

Figure 112019033830618-pat00035
Figure 112019033830618-pat00035

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 2-에티닐-4-메톡시아닐린(2-ethynyl-4-methoxyaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 6에 따른 4-브로모-2-플루오로-6-메톡시퀴놀린(4-bromo-2-fluoro-6-methoxyquinoline)을 얻었다. 상기 4-브로모-2-플루오로-6-메톡시퀴놀린(4-bromo-2-fluoro-6-methoxyquinoline)은 하기의 화학식 9로 나타낸다.In addition, instead of 2-ethynylaniline, 2-ethynyl-4-methoxyaniline was used, and instead of white LED (18W, EvoluChem company), 365 nm ( 18W, EvoluChem compan) 4-bromo-2-fluoro-6-methoxyquinoline (4-bromo-2- fluoro-6-methoxyquinoline) was obtained. The 4-bromo-2-fluoro-6-methoxyquinoline is represented by Formula 9 below.

<화학식 9><Formula 9>

Figure 112019033830618-pat00036
Figure 112019033830618-pat00036

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 2-에티닐-5-메톡시아닐린(2-ethynyl-5-methoxyaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 7에 따른 4-브로모-2-플로오로-7-메톡시퀴놀린(4-bromo-2-fluoro-7-methoxyquinoline)을 얻었다. 상기 4-브로모-2-플로오로-7-메톡시퀴놀린(4-bromo-2-fluoro-7-methoxyquinoline)은 하기의 화학식 10으로 나타낸다.In addition, instead of 2-ethynylaniline, 2-ethynyl-5-methoxyaniline was used, and instead of white LED (18W, EvoluChem company), 365 nm ( 18W, EvoluChem compan) through substantially the same process as in Example 1, 4-bromo-2-fluoro-7-methoxyquinoline (4-bromo-2- fluoro-7-methoxyquinoline) was obtained. The 4-bromo-2-fluoro-7-methoxyquinoline is represented by Formula 10 below.

<화학식 10><Formula 10>

Figure 112019033830618-pat00037
Figure 112019033830618-pat00037

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 메틸 4-아미노-5-에티닐벤조에이트(methyl 4-amino-3-ethynylbenzoate)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 8에 따른 4-브로모-6-카보메톡시-2-플루오로퀴놀린(4-bromo-6-carbomethoxy-2-fluoroquinoline)을 얻었다. 상기 4-브로모-6-카보메톡시-2-플루오로퀴놀린(4-bromo-6-carbomethoxy-2-fluoroquinoline)은 하기의 화학식 11로 나타낸다.In addition, instead of 2-ethynylaniline, methyl 4-amino-3-ethynylbenzoate was used, and instead of white LED (18W, EvoluChem company), 365 4-bromo-6-carbomethoxy-2-fluoroquinoline (4-bromo) according to Example 8 of the present invention through substantially the same process as in Example 1 except that nm (18W, EvoluChem compan) was used. -6-carbomethoxy-2-fluoroquinoline) was obtained. The 4-bromo-6-carbomethoxy-2-fluoroquinoline is represented by Formula 11 below.

<화학식 11><Formula 11>

Figure 112019033830618-pat00038
Figure 112019033830618-pat00038

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 4-아미노-5-에티닐벤조니트릴(4-amino-3-ethynylbenzonitrile)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 9에 따른 4-브로모-6-시아노-2-플루오로퀴놀린(4-bromo-6-cyano-2-fluoroquinoline)을 얻었다. 상기 4-브로모-6-시아노-2-플루오로퀴놀린(4-bromo-6-cyano-2-fluoroquinoline)는 하기의 화학식 12로 나타낸다.In addition, instead of 2-ethynylaniline, 4-amino-5-ethynylbenzonitrile was used, and instead of white LED (18W, EvoluChem company), 365 nm ( 18W, EvoluChem compan) 4-bromo-6-cyano-2-fluoroquinoline according to Example 9 of the present invention through substantially the same process as in Example 1 (4-bromo-6- cyano-2-fluoroquinoline) was obtained. The 4-bromo-6-cyano-2-fluoroquinoline is represented by the following formula (12).

<화학식 12><Formula 12>

Figure 112019033830618-pat00039
Figure 112019033830618-pat00039

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 2-브로모-6-에티닐-4-메틸아닐린(2-bromo-6-ethynyl-4-methylaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 10에 따른 4,8-디브로모-2-플루오로-6-메틸퀴놀린(4,8-dibromo-2-fluoro-6-methylquinoline)을 얻었다. 상기 4,8-디브로모-2-플루오로-6-메틸퀴놀린(4,8-dibromo-2-fluoro-6-methylquinoline)은 하기의 화학식 13으로 나타낸다.In addition, instead of 2-ethynylaniline, 2-bromo-6-ethynyl-4-methylaniline (2-bromo-6-ethynyl-4-methylaniline) was used, and a white LED (18W, EvoluChem company), 4,8-dibromo-2-fluoro-6 according to Example 10 of the present invention through substantially the same process as in Example 1 except that 365 nm (18W, EvoluChem compan) was used. -Methylquinoline (4,8-dibromo-2-fluoro-6-methylquinoline) was obtained. The 4,8-dibromo-2-fluoro-6-methylquinoline (4,8-dibromo-2-fluoro-6-methylquinoline) is represented by the following formula (13).

<화학식 13><Formula 13>

Figure 112019033830618-pat00040
Figure 112019033830618-pat00040

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 4-브로모-2-에티닐아닐린(4-bromo-2-ethynylaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 11에 따른 4,6-디보로모-2-플루오로퀴놀린(4,6-dibromo-2-fluoroquinoline)을 얻었다. 상기 4,6-디보로모-2-플루오로퀴놀린(4,6-dibromo-2-fluoroquinoline)은 하기의 화학식 14로 나타낸다.In addition, instead of 2-ethynylaniline, 4-bromo-2-ethynylaniline was used, and instead of white LED (18W, EvoluChem company), 365 nm ( 18W, EvoluChem compan) through substantially the same process as in Example 1, 4,6-dibromo-2-fluoroquinoline according to Example 11 of the present invention (4,6-dibromo-2-fluoroquinoline ). The 4,6-dibromo-2-fluoroquinoline is represented by the following formula (14).

<화학식 14><Formula 14>

Figure 112019033830618-pat00041
Figure 112019033830618-pat00041

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 5-브로모-2-에티닐아닐린(5-bromo-2-ethynylaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 12에 따른 4,7-디브로모-2-플루오로퀴놀린(4,7-dibromo-2-fluoroquinoline)을 얻었다. 상기 4,7-디브로모-2-플루오로퀴놀린(4,7-dibromo-2-fluoroquinoline)은 하기의 화학식 15로 나타낸다.In addition, instead of 2-ethynylaniline, 5-bromo-2-ethynylaniline was used, and instead of white LED (18W, EvoluChem company), 365 nm ( 18W, EvoluChem compan) 4,7-dibromo-2-fluoroquinoline (4,7-dibromo-2- fluoroquinoline) was obtained. The 4,7-dibromo-2-fluoroquinoline is represented by the following formula (15).

<화학식 15><Formula 15>

Figure 112019033830618-pat00042
Figure 112019033830618-pat00042

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 4-클로로-2-에티닐아닐린(4-chloro-2-ethynylaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 13에 따른 4-브로모-6-클로로-2-플루오로퀴놀린(4-bromo-6-chloro-2-fluoroquinoline)을 얻었다. 상기 4-브로모-6-클로로-2-플루오로퀴놀린(4-bromo-6-chloro-2-fluoroquinoline)은 하기의 화학식 16으로 나타낸다.In addition, instead of 2-ethynylaniline, 4-chloro-2-ethynylaniline was used, and instead of white LED (18W, EvoluChem company), 365 nm (18W) was used. , EvoluChem compan) 4-bromo-6-chloro-2-fluoroquinoline according to Example 13 of the present invention through substantially the same process as in Example 1 (4-bromo-6-chloro- 2-fluoroquinoline) was obtained. The 4-bromo-6-chloro-2-fluoroquinoline is represented by the following formula (16).

<화학식 16><Formula 16>

Figure 112019033830618-pat00043
Figure 112019033830618-pat00043

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 5-클로로-2-에티닐아닐린(5-chloro-2-ethynylaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 14에 따른 4-브로모-7-클로로-2-플루오로퀴놀린(4-bromo-7-chloro-2-fluoroquinoline)을 얻었다. 상기 4-브로모-7-클로로-2-플루오로퀴놀린(4-bromo-7-chloro-2-fluoroquinoline)을 하기의 화학식 17로 나타낸다.In addition, instead of 2-ethynylaniline, 5-chloro-2-ethynylaniline was used, and instead of white LED (18W, EvoluChem company), 365 nm (18W) was used. , EvoluChem compan) 4-bromo-7-chloro-2-fluoroquinoline according to Example 14 of the present invention through substantially the same process as in Example 1 (4-bromo-7-chloro- 2-fluoroquinoline) was obtained. The 4-bromo-7-chloro-2-fluoroquinoline is represented by the following formula (17).

<화학식 17><Formula 17>

Figure 112019033830618-pat00044
Figure 112019033830618-pat00044

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 2,4-디클로로-6-에티닐아닐린(2,4-dichloro-6-ethynylaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 15에 따른 4-브로모-6,8-디클로로-2-플루오로퀴놀린(4-bromo-6,8-dichloro-2-fluoroquinoline)을 얻었다. 상기 4-브로모-6,8-디클로로-2-플루오로퀴놀린(4-bromo-6,8-dichloro-2-fluoroquinoline)은 하기의 화학식 18로 나타낸다.In addition, instead of 2-ethynylaniline, 2,4-dichloro-6-ethynylaniline was used, and instead of white LED (18W, EvoluChem company), 4-bromo-6,8-dichloro-2-fluoroquinoline (4-bromo-6,8-dichloro-2-fluoroquinoline according to Example 15 of the present invention through substantially the same process as in Example 1 except that 365 nm (18W, EvoluChem compan) was used. bromo-6,8-dichloro-2-fluoroquinoline) was obtained. The 4-bromo-6,8-dichloro-2-fluoroquinoline is represented by the following formula (18).

<화학식 18><Formula 18>

Figure 112019033830618-pat00045
Figure 112019033830618-pat00045

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 4-클로로-2-에티닐-6-플루오로아닐린(4-chloro-2-ethynyl-6-fluoroaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem compan)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 16에 따른 4-브로모-6-클로로-2,8-디플루오로퀴놀린(4-bromo-6-chloro-2,8-difluoroquinoline)을 얻었다. 상기 4-브로모-6-클로로-2,8-디플루오로퀴놀린(4-bromo-6-chloro-2,8-difluoroquinoline)은 하기의 화학식 19로 나타낸다.In addition, instead of 2-ethynylaniline, 4-chloro-2-ethynyl-6-fluoroaniline was used, and a white LED (18W, EvoluChem company), 4-bromo-6-chloro-2,8-di according to Example 16 of the present invention through substantially the same process as in Example 1 except that 365 nm (18W, EvoluChem compan) was used. Fluoroquinoline (4-bromo-6-chloro-2,8-difluoroquinoline) was obtained. The 4-bromo-6-chloro-2,8-difluoroquinoline is represented by the following formula (19).

<화학식 19><Formula 19>

Figure 112019033830618-pat00046
Figure 112019033830618-pat00046

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 2-에티닐-4-플루오로아닐린(2-ethynyl-4-fluoroaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem company)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 17에 따른 4-브로모-2,6-디플루오로퀴놀린(4-bromo-2,6-difluoroquinoline)을 얻었다. 상기 4-브로모-2,6-디플루오로퀴놀린(4-bromo-2,6-difluoroquinoline)은 하기의 화학식 20으로 나타낸다.In addition, instead of 2-ethynylaniline, 2-ethynyl-4-fluoroaniline was used, and in place of a white LED (18W, EvoluChem company), 365 nm ( 18W, EvoluChem company) through substantially the same process as in Example 1, 4-bromo-2,6-difluoroquinoline (4-bromo-2,6- difluoroquinoline) was obtained. The 4-bromo-2,6-difluoroquinoline is represented by the following formula (20).

<화학식 20><Formula 20>

Figure 112019033830618-pat00047
Figure 112019033830618-pat00047

2-에티닐 아닐린(2-ethynylaniline) 대신, 2-에티닐-5-플루오로아닐린(2-ethynyl-5-fluoroaniline)을 이용하고, 백색 LED (18W, EvoluChem company) 대신, 365 nm(18W, EvoluChem company)를 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 18에 따른 4-브로모-2,7-디플루오로퀴놀린(4-bromo-2,7-difluoroquinoline)을 얻었다. 상기 4-브로모-2,7-디플루오로퀴놀린(4-bromo-2,7-difluoroquinoline)은 화학식 21로 나타낸다.Instead of 2-ethynylaniline, 2-ethynyl-5-fluoroaniline was used, and instead of white LED (18W, EvoluChem company), 365 nm (18W, EvoluChem company) through substantially the same process as in Example 1, 4-bromo-2,7-difluoroquinoline according to Example 18 of the present invention (4-bromo-2,7-difluoroquinoline) Got it. The 4-bromo-2,7-difluoroquinoline is represented by Chemical Formula 21.

<화학식 21><Formula 21>

Figure 112019033830618-pat00048
Figure 112019033830618-pat00048

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 2,4-디에티닐나프탈렌-1-아민 (2,4-diethynylnaphthalen-1-amine)을 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 19에 따른 4-브로모-2-풀루오로벤조[h]퀴놀린(4-bromo-2-fluorobenzo[h]quinoline)을 얻었다. 상기 4-브로모-2-풀루오로벤조[h]퀴놀린(4-bromo-2-fluorobenzo[h]quinoline)은 하기의 화학식 22로 나타낸다.In addition, substantially the same process as in Example 1 except for using 2,4-diethynylnaphthalen-1-amine (2,4-diethynylnaphthalen-1-amine) instead of 2-ethynylaniline Through the 4-bromo-2-fluorobenzo[h]quinoline (4-bromo-2-fluorobenzo[h]quinoline) according to Example 19 of the present invention was obtained. The 4-bromo-2-fluorobenzo[h]quinoline is represented by the following formula (22).

<화학식 22><Formula 22>

Figure 112019033830618-pat00049
Figure 112019033830618-pat00049

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 2-(옥트-1-인-1-일)아닐린 (2-(oct-1-yn-1-yl)aniline)을 이용하고, 대신, 365 nm(600W, EvoluChem company)하에서 2시간 동안 반응시킨 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 20에 따른 4-브로모-3-헥실-2-플루오로퀴놀린(4-bromo-3-hexyl-2-fluoroquinoline)을 얻었따. 상기 4-브로모-3-헥실-2-플루오로퀴놀린(4-bromo-3-hexyl-2-fluoroquinoline)은 화학식 23으로 나타낸다.In addition, the use of aniline (2-ethynylaniline) instead of 2- (oct-1-yl) aniline (2- (oct-1-yn -1-yl) aniline) and 2-ethynyl, instead, 4-bromo-3-hexyl-2-fluoroquinoline according to Example 20 of the present invention through substantially the same process as in Example 1 except that the reaction was carried out under 365 nm (600W, EvoluChem company) for 2 hours. 4-bromo-3-hexyl-2-fluoroquinoline) was obtained. The 4-bromo-3-hexyl-2-fluoroquinoline is represented by Chemical Formula 23.

<화학식 23><Formula 23>

Figure 112019033830618-pat00050
Figure 112019033830618-pat00050

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 4,6-디에티닐-2-아이오도벤젠-1,3-다이아민(4,6-diethynyl-2-iodobenzene-1,3-diamine)을 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 41에 따른 7-아미노-4-브로모-6-에티닐-2-플루오로-8-아이오도퀴놀린(7-amino-4-bromo-6-ethynyl-2-fluoro-8-iodoquinoline)을 얻었다. 상기 7-아미노-4-브로모-6-에티닐-2-플루오로-8-아이오도퀴놀린(7-amino-4-bromo-6-ethynyl-2-fluoro-8-iodoquinoline)은 하기의 화학식 24로 나타낸다.In addition, instead of 2-ethynylaniline, 4,6-diethynyl-2-iodobenzene-1,3-diamine (4,6-diethynyl-2-iodobenzene-1,3-diamine) 7-amino-4-bromo-6-ethynyl-2-fluoro-8-iodoquinoline (7- amino-4-bromo-6-ethynyl-2-fluoro-8-iodoquinoline) was obtained. The 7-amino-4-bromo-6-ethynyl-2-fluoro-8-iodoquinoline is represented by the following formula It is represented by 24.

<화학식 24><Formula 24>

Figure 112019033830618-pat00051
Figure 112019033830618-pat00051

또한, 2-에티닐 아닐린(2-ethynylaniline) 대신, 2-에티닐-피리딘-3-아민(2-ethynylpyridin-3-amine)을 이용한 것을 제외하고 실시예 1과 실질적으로 동일한 공정을 통해서 본 발명의 실시예 42에 따른 4-브로모-2-플루오로-1,5-나프티리딘(4-bromo-2-fluoro-1,5-napthyrdine)을 얻었다. 상기 4-브로모-2-플루오로-1,5-나프티리딘(4-bromo-2-fluoro-1,5-napthyrdine)은 하기의 화학식 25로 나타낸다.In addition, the present invention through substantially the same process as in Example 1, except for using 2-ethynyl-pyridin-3-amine (2-ethynylpyridin-3-amine) instead of 2-ethynyl aniline (2-ethynylaniline) To obtain 4-bromo-2-fluoro-1,5-naphthyrdine (4-bromo-2-fluoro-1,5-napthyrdine) according to Example 42 of. The 4-bromo-2-fluoro-1,5-napthyrdine is represented by the following formula (25).

<화학식 25><Formula 25>

Figure 112019033830618-pat00052
Figure 112019033830618-pat00052

상기에서는 본 발명의 바람직한 실시예를 참조하여 설명하였지만, 해당 기술 분야의 숙련된 당업자는 하기의 특허 청구 범위에 기재된 본 발명의 사상 및 영역으로부터 벗어나지 않는 범위 내에서 본 발명을 다양하게 수정 및 변경시킬 수 있음을 이해할 수 있을 것이다.Although the above has been described with reference to preferred embodiments of the present invention, those skilled in the art will be able to variously modify and change the present invention without departing from the spirit and scope of the present invention described in the following claims. You will understand that you can.

Claims (11)

트리브로모플루오로메탄과 아래 화학식 1의 치환된 또는 비치환된 2-알키닐 아닐린 화합물을 반응시킴을 포함하는,
아래 화학식 2의 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린의 제조 방법.
<화학식 1>
Figure 112021026691720-pat00078

(상기 화학식 1에서, R1 및 R2 은 각각 독립적으로 수소, 할로겐, 시아노, 탄소수 1 내지 10개의 알킬기(alkyl), 탄소수 6 내지 20개의 아릴기(Aryl), 탄소수 2 내지 10개의 알케닐 또는 탄소수 1 내지 10개의 알콕시이다.)
<화학식 2>
Figure 112021026691720-pat00079

(상기 화학식 2에서, R1 및 R2 은 각각 독립적으로 수소, 할로겐, 시아노, 탄소수 1 내지 10개의 알킬기(alkyl), 탄소수 6 내지 20개의 아릴기(Aryl), 탄소수 2 내지 10개의 알케닐 또는 탄소수 1 내지 10개의 알콕시이다.)
Comprising reacting tribromofluoromethane with a substituted or unsubstituted 2-alkynyl aniline compound of Formula 1 below,
A method for preparing a substituted or unsubstituted 4-bromo-2-fluoroquinoline of Formula 2 below.
<Formula 1>
Figure 112021026691720-pat00078

(In Formula 1, R1 and R2 are each independently hydrogen, halogen, cyano, an alkyl group having 1 to 10 carbon atoms, an aryl group having 6 to 20 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, or 1 to 10 alkoxy.)
<Formula 2>
Figure 112021026691720-pat00079

(In Chemical Formula 2, R1 and R2 are each independently hydrogen, halogen, cyano, an alkyl group having 1 to 10 carbon atoms, an aryl group having 6 to 20 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, or 1 to 10 alkoxy.)
제1항에 있어서,
상기 반응은 아민 염기성 용액 내에 이뤄짐을 특징으로 하는,
치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린의 제조 방법.
The method of claim 1,
The reaction is characterized in that it takes place in an amine basic solution,
A method for producing a substituted or unsubstituted 4-bromo-2-fluoroquinoline.
제1항에 있어서,
상기 반응은 광을 조사하면서 이뤄짐을 특징으로 하는,
치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린의 제조 방법.
The method of claim 1,
The reaction is characterized in that it takes place while irradiating light,
A method for producing a substituted or unsubstituted 4-bromo-2-fluoroquinoline.
제2항에 있어서,
상기 아민 염기성 용액은 NMM, DABCO, DBU, TEA, TMEDA, 및 N-벤질메틸아민(N-benzylmethylamine) 중 어느 하나 이상의 용액임을 특징으로 하는,
치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린의 제조 방법.
The method of claim 2,
The amine basic solution is characterized in that it is any one or more of NMM, DABCO, DBU, TEA, TMEDA, and N-benzylmethylamine,
A method for producing a substituted or unsubstituted 4-bromo-2-fluoroquinoline.
제2항에 있어서,
상기 용액의 용매는 DMF, DMSO, THF, 1,4-디옥산(1,4-dioxane), NMP, MeCN, 벤젠(benzene), H2O 및 DCE 중 어느 하나 이상임을 특징으로 하는,
치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린의 제조 방법.
The method of claim 2,
The solvent of the solution is any one or more of DMF, DMSO, THF, 1,4-dioxane, NMP, MeCN, benzene, H2O, and DCE,
A method for producing a substituted or unsubstituted 4-bromo-2-fluoroquinoline.
제2항에 있어서,
상기 용액의 용매는 염소계 용매임을 특징으로 하는,
치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린의 제조 방법.
The method of claim 2,
The solvent of the solution is characterized in that the chlorine-based solvent,
A method for producing a substituted or unsubstituted 4-bromo-2-fluoroquinoline.
제1항에 있어서,
상기 반응은 무산소 분위기에서 수행함을 특징으로 하는,
치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린의 제조 방법.
The method of claim 1,
The reaction is characterized in that to be carried out in an oxygen-free atmosphere,
A method for producing a substituted or unsubstituted 4-bromo-2-fluoroquinoline.
삭제delete 아래 화학식2의 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물:
<화학식 2>
Figure 112021026691720-pat00054

상기 화학식 2에서, R1 및 R2 은 각각 독립적으로 수소, 할로겐, 시아노, 탄소수 1 내지 10개의 알킬기(alkyl), 탄소수 6 내지 20개의 아릴기(Aryl), 탄소수 2 내지 10개의 알케닐 또는 탄소수 1 내지 10개의 알콕시이다.
Substituted or unsubstituted 4-bromo-2-fluoroquinoline compound of Formula 2 below:
<Formula 2>
Figure 112021026691720-pat00054

In Formula 2, R1 and R2 are each independently hydrogen, halogen, cyano, an alkyl group having 1 to 10 carbon atoms, an aryl group having 6 to 20 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, or 1 To 10 alkoxy.
제9항에 있어서,
상기 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물은 아래 화학식임을 특징으로 하는, 치환된 또는 비치환된 4-브로모-2-플루오로퀴놀린 화합물:
Figure 112020111055009-pat00055

Figure 112020111055009-pat00056

Figure 112020111055009-pat00057

Figure 112020111055009-pat00058

Figure 112020111055009-pat00059

Figure 112020111055009-pat00060

Figure 112020111055009-pat00061

Figure 112020111055009-pat00062

Figure 112020111055009-pat00063

Figure 112020111055009-pat00064

Figure 112020111055009-pat00065

Figure 112020111055009-pat00066

Figure 112020111055009-pat00067

Figure 112020111055009-pat00068

Figure 112020111055009-pat00069

Figure 112020111055009-pat00070

Figure 112020111055009-pat00071

Figure 112020111055009-pat00072

Figure 112020111055009-pat00073

Figure 112020111055009-pat00074

Figure 112020111055009-pat00075
The method of claim 9,
The substituted or unsubstituted 4-bromo-2-fluoroquinoline compound is a substituted or unsubstituted 4-bromo-2-fluoroquinoline compound, characterized in that it has the following formula:
Figure 112020111055009-pat00055

Figure 112020111055009-pat00056

Figure 112020111055009-pat00057

Figure 112020111055009-pat00058

Figure 112020111055009-pat00059

Figure 112020111055009-pat00060

Figure 112020111055009-pat00061

Figure 112020111055009-pat00062

Figure 112020111055009-pat00063

Figure 112020111055009-pat00064

Figure 112020111055009-pat00065

Figure 112020111055009-pat00066

Figure 112020111055009-pat00067

Figure 112020111055009-pat00068

Figure 112020111055009-pat00069

Figure 112020111055009-pat00070

Figure 112020111055009-pat00071

Figure 112020111055009-pat00072

Figure 112020111055009-pat00073

Figure 112020111055009-pat00074

Figure 112020111055009-pat00075
삭제delete
KR1020190038505A 2018-12-03 2019-04-02 Substituted or unsubstituted 4-bromo-2-fluoroquinoline, method of the same and 2,4 substituted quinoline compounds containing them KR102242238B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20180153692 2018-12-03
KR1020180153692 2018-12-03

Publications (2)

Publication Number Publication Date
KR20200067073A KR20200067073A (en) 2020-06-11
KR102242238B1 true KR102242238B1 (en) 2021-04-20

Family

ID=71070704

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190038505A KR102242238B1 (en) 2018-12-03 2019-04-02 Substituted or unsubstituted 4-bromo-2-fluoroquinoline, method of the same and 2,4 substituted quinoline compounds containing them

Country Status (1)

Country Link
KR (1) KR102242238B1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019456A1 (en) 1994-12-21 1996-06-27 Bnfl Fluorochemicals Ltd. Process for the preparation of fluorinated heterocyclic compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019456A1 (en) 1994-12-21 1996-06-27 Bnfl Fluorochemicals Ltd. Process for the preparation of fluorinated heterocyclic compounds

Also Published As

Publication number Publication date
KR20200067073A (en) 2020-06-11

Similar Documents

Publication Publication Date Title
TW200948361A (en) Method for synthesizing Biolimus A9 and the like and method for improving stability of the same
CN108148069B (en) Synthetic method of furanone pyridone compound
CN110483420B (en) Preparation method of tetrahydroquinoxaline compound
KR102242238B1 (en) Substituted or unsubstituted 4-bromo-2-fluoroquinoline, method of the same and 2,4 substituted quinoline compounds containing them
CN111285881B (en) Thieno [3,4-b ] indole derivative and synthetic method thereof
CN111763163A (en) Preparation method of diphenyl disulfide compound
CN108276300B (en) Method for preparing biphenyl triarylamine compound by using carboxyl as guide group, intermediate and preparation method thereof
CN104046351B (en) There is the luminous organic material of afterglow performance and synthetic method thereof and application
CN112939891B (en) Method for preparing biphenyl benzothiazole compound
CN112390696B (en) Method for preparing alpha-aminonitrile, product and application thereof
JP5330066B2 (en) Method for producing triarylamine compound
JP2008063240A (en) Method for producing anthracene compound
CN114349609A (en) Synthetic method of hexabenzocoronene dimer
WO2016197580A1 (en) Method of synthesizing α-amino acid derivative with α-alkyl side chain substitution
CN108610306B (en) Synthetic method of 2H-1, 4-thiazine-3 (4H) -ketone derivative
JP2016538251A (en) Method for producing 3-alkylthio-2-bromopyridine
WO2019035453A1 (en) Catalyst, method for forming amide bond, and method for producing amide compound
CN110590641B (en) Green preparation method of 3-hydroxyisoindole-1-ketone series compounds
RU2522460C1 (en) Method of producing alkenyl anthraquinones
CN114685415B (en) Synthesis method of kojic acid dimer
KR101006737B1 (en) Process for the preparation of 2-sulfonyliminoindoline using Cu catalyst
CN110343047B (en) Preparation method of aminopyrene compound
CN117263839A (en) Synthesis method of substituted nitrogen heterocyclic compound
CN107445871B (en) Preparation method of α -benezenesulfonic acid derivative with optical activity
WO2007105622A1 (en) Method for producing heterocyclic compound

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
X091 Application refused [patent]
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant